These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11841346)

  • 21. Regulation of human squamous cell carcinoma plasma membrane associated urokinase plasminogen activator by epidermal growth factor.
    Niedbala MJ; Bajetta S; Carbone R; Sartorelli AC
    Cancer Commun; 1990; 2(9):317-24. PubMed ID: 2169831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor.
    Albo D; Rothman VL; Roberts DD; Tuszynski GP
    Br J Cancer; 2000 Aug; 83(3):298-306. PubMed ID: 10917542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
    Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
    Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermolecular contact regions in urokinase plasminogen activator receptor.
    Liang OD; Bdeir K; Matz RL; Chavakis T; Preissner KT
    J Biochem; 2003 Nov; 134(5):661-6. PubMed ID: 14688231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.
    Boutaud A; Castellino FJ
    Arch Biochem Biophys; 1993 Jun; 303(2):222-30. PubMed ID: 8512311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UVB increases urokinase-type plasminogen activator receptor (uPAR) expression.
    Marschall C; Lengyel E; Nobutoh T; Braungart E; Douwes K; Simon A; Magdolen V; Reuning U; Degitz K
    J Invest Dermatol; 1999 Jul; 113(1):69-76. PubMed ID: 10417621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice.
    List K; Jensen ON; Bugge TH; Lund LR; Ploug M; Danø K; Behrendt N
    Biochemistry; 2000 Jan; 39(3):508-15. PubMed ID: 10642175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.
    Ellis V; Whawell SA; Werner F; Deadman JJ
    Biochemistry; 1999 Jan; 38(2):651-9. PubMed ID: 9888805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor.
    Ballance DJ; Marshall JM; Cottingham IR; Steven J; Berry SJ; Cederholm-Williams SA; Goodey AR; Courtney M
    Eur J Biochem; 1992 Jul; 207(1):177-83. PubMed ID: 1321039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential inhibition of endothelial cell proliferation and migration by urokinase subdomains: amino-terminal fragment and kringle domain.
    Kim KS; Hong YK; Lee Y; Shin JY; Chang SI; Chung SI; Joe Y
    Exp Mol Med; 2003 Dec; 35(6):578-85. PubMed ID: 14749538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
    Wells JM; Strickland S
    J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal growth factor-binding protein activates soluble and receptor-bound single chain urokinase-type plasminogen activator.
    Wolf BB; Brown MD
    FEBS Lett; 1995 Dec; 376(3):177-80. PubMed ID: 7498536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The structure basis of the poor fibrin specificity of urokinase (II)--The inhibition of urokinase A chain 149-157 on the fibrin stimulated activation of plasminogen by tissue type plasminogen activator.
    Song A; Liu JN; Yu RR; Cui DF; Zhou TM; Cui HR; Zhu DX
    Sci China B; 1992 Aug; 35(8):966-73. PubMed ID: 1338753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.
    Yin S; Lockett J; Meng Y; Biliran H; Blouse GE; Li X; Reddy N; Zhao Z; Lin X; Anagli J; Cher ML; Sheng S
    Cancer Res; 2006 Apr; 66(8):4173-81. PubMed ID: 16618739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoprotein-receptor-related protein.
    Andersen OM; Petersen HH; Jacobsen C; Moestrup SK; Etzerodt M; Andreasen PA; Thøgersen HC
    Biochem J; 2001 Jul; 357(Pt 1):289-96. PubMed ID: 11415462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of cell migration and invasion by specific modules of uPA: mechanistic insights and specific inhibitors.
    Carriero MV; Franco P; Votta G; Longanesi-Cattani I; Vento MT; Masucci MT; Mancini A; Caputi M; Iaccarino I; Stoppelli MP
    Curr Drug Targets; 2011 Nov; 12(12):1761-71. PubMed ID: 21707476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggregated low-density lipoprotein induce impairment of the cytoskeleton dynamics through urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor in human vascular smooth muscle cell.
    Lugano R; Peña E; Badimon L; Padró T
    J Thromb Haemost; 2012 Oct; 10(10):2158-67. PubMed ID: 22906080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.
    Plow EF; Freaney DE; Plescia J; Miles LA
    J Cell Biol; 1986 Dec; 103(6 Pt 1):2411-20. PubMed ID: 3023400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Yeast expression and phagemid display of the human urokinase plasminogen activator epidermal growth factor-like domain.
    Stratton-Thomas JR; Min HY; Kaufman SE; Chiu CY; Mullenbach GT; Rosenberg S
    Protein Eng; 1995 May; 8(5):463-70. PubMed ID: 8532668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proliferation of a human epidermal tumor cell line stimulated by urokinase.
    Kirchheimer JC; Wojta J; Christ G; Binder BR
    FASEB J; 1987 Aug; 1(2):125-8. PubMed ID: 3038646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.